What is Basivertebral Nerve Ablation
A Different Kind of Back Pain
Most people who come in with chronic low back pain have already been through the standard workup — X-rays, MRI, maybe a course of physical therapy, possibly some injections. And for many of them, the imaging shows degenerative changes in the spine that seem like they should explain the pain. But sometimes the standard treatments do not provide lasting relief, and the question becomes: why not?
The answer, in a meaningful subset of patients, is that the pain is coming from a source that has historically been difficult to both identify and treat — the vertebral endplates and the nerve that supplies them. This is called vertebrogenic pain, and until recently there was no good targeted treatment for it. Basivertebral nerve ablation changes that.
Understanding the Anatomy: The Vertebral Endplate and the Basivertebral Nerve
To understand why this procedure exists, it helps to understand a bit of anatomy that does not get much attention outside of specialty spine care.
Each spinal disc sits between two vertebral bodies — the bony blocks that make up your spine. The top and bottom surfaces of each vertebral body where it contacts the disc are called the vertebral endplates. These endplates are thin layers of bone and cartilage that act as the interface between the disc and the vertebral body. They are involved in nutrient exchange for the disc and play an important role in spinal load distribution.
Running through the center of each vertebral body is a small nerve called the basivertebral nerve. This nerve enters the back of the vertebral body through a small channel in the bone and branches out to supply the vertebral endplates. The basivertebral nerve is a purely sensory nerve — it does not control any muscle function — and its sole job is to transmit pain signals from the endplate to the brain.
Under normal circumstances and in a healthy spine, this nerve does not generate significant pain. But when the vertebral endplates become damaged or inflamed — as happens with certain patterns of disc degeneration — the basivertebral nerve can become sensitized and begin firing chronic pain signals that do not resolve on their own.
What Is Vertebrogenic Pain?
Vertebrogenic pain — sometimes called discovertebrogenic pain — refers specifically to chronic low back pain that originates from the vertebral endplates and the basivertebral nerve, rather than from the disc material itself, the facet joints, the sacroiliac joint, or the surrounding muscles and ligaments.
It is an important distinction because vertebrogenic pain has a specific biological mechanism, a specific imaging signature, and now a specific treatment. Lumping it in with generic chronic back pain leads to treatments that address the wrong target.
The underlying process works like this. As spinal discs degenerate over time, the vertebral endplates that border the disc can sustain damage — microfractures, inflammation, and structural changes that alter the local tissue environment. In response to this endplate stress, the bone immediately adjacent to the endplate can undergo changes that are visible on MRI. These changes — called Modic changes — represent edema, fatty infiltration, or sclerosis of the bone adjacent to the endplate, and they have been closely linked to chronic vertebrogenic pain.
Not every patient with Modic changes has vertebrogenic pain, and not every patient with vertebrogenic pain has dramatic Modic changes. But the presence of Type 1 or Type 2 Modic changes on MRI — particularly when they correlate with the location of the patient's pain — is an important clinical clue that the basivertebral nerve may be the pain generator.
What Are Modic Changes and Why Do They Matter?
Modic changes are a classification system used to describe specific signal changes seen on MRI in the vertebral bodies adjacent to a degenerated disc. They were first described by radiologist Michael Modic in the 1980s and have since become an important part of how spine physicians interpret MRI findings.
There are three types:
Type 1 Modic Changes represent active inflammation and bone marrow edema in the vertebral body adjacent to the endplate. These are associated with the highest levels of pain and inflammatory activity and appear as bright signal on certain MRI sequences. Type 1 changes are the most strongly associated with vertebrogenic pain and the best predictor of response to basivertebral nerve ablation.
Type 2 Modic Changes represent fatty replacement of the bone marrow adjacent to the endplate — a more chronic, burned-out phase of the same process. These are also associated with vertebrogenic pain and are a positive predictor of treatment response, though the evidence is slightly less robust than for Type 1.
Type 3 Modic Changes represent bony sclerosis — a hardening and densification of the vertebral bone — and are less commonly associated with active pain.
The presence of Type 1 or Type 2 Modic changes at one or two spinal levels, in a patient whose pain distribution and clinical presentation are consistent with those levels, is the primary imaging criterion used to identify candidates for basivertebral nerve ablation.
What Is Basivertebral Nerve Ablation?
Basivertebral nerve ablation — also called BVN ablation or the INTRACEPT procedure, which is the name of the FDA-cleared device used to perform it — is a minimally invasive procedure that uses radiofrequency energy to ablate, or disrupt, the basivertebral nerve inside the vertebral body. By interrupting the nerve's ability to transmit pain signals from the damaged endplate, the procedure aims to provide lasting relief from vertebrogenic chronic low back pain.
This is conceptually similar to radiofrequency ablation of the medial branch nerves for facet joint pain — the same principle of using targeted heat to disrupt a specific pain-carrying nerve — but applied to a nerve inside the vertebral body rather than on the surface of the spine.
It is not surgery in the traditional sense. There are no large incisions, no removal of disc material, no fusion of vertebrae, and no implanted hardware. The procedure is performed through a small working channel introduced into the back of the vertebral body through a technique similar to a vertebroplasty or bone biopsy approach.
Who Is a Good Candidate?
Basivertebral nerve ablation is indicated for a specific and well-defined patient population. Not everyone with chronic low back pain is a candidate, and appropriate patient selection is one of the most important factors in achieving good outcomes.
You may be a good candidate if:
You have chronic low back pain that has persisted for six months or longer
Your pain is primarily axial — meaning it is centered in the low back rather than radiating significantly into the legs
Your MRI shows Type 1 or Type 2 Modic changes at one or two lumbar vertebral levels that correlate with your pain
You have tried and not achieved lasting relief from conservative treatments including physical therapy, activity modification, and medications
Facet joint pain, sacroiliac joint pain, and other specific pain generators have been evaluated and determined not to be the primary source of your symptoms
You do not have significant spinal instability, active infection, severe spinal stenosis requiring decompression, or other structural problems that require surgical intervention
The procedure is currently FDA-cleared for treatment at one or two lumbar levels at a time. Most commonly treated levels are L4-L5 and L5-S1, though other lumbar levels can be addressed depending on where the Modic changes are located.
What Does the Evidence Say?
Basivertebral nerve ablation has one of the strongest evidence bases of any minimally invasive spine procedure currently available, supported by multiple well-designed clinical trials including a landmark sham-controlled randomized controlled trial — the highest standard of evidence in interventional medicine.
The SMART Trial
The Sham-controlled, Multicenter, Randomized Trial — known as the SMART trial — was published in the journal Spine and is the pivotal study establishing the efficacy of basivertebral nerve ablation. In this trial, patients with chronic low back pain and Modic changes were randomized to receive either the actual BVN ablation procedure or a sham procedure — a placebo intervention performed with the same setup and anesthesia but without delivering radiofrequency energy.
At three months, patients who received the actual ablation showed significantly greater reductions in pain and disability compared to the sham group. Importantly, the sham group was then offered the real procedure, and when followed out to one and two years, patients who underwent BVN ablation showed sustained and clinically meaningful improvements in pain scores, disability scores, and quality of life measures.
The two-year outcomes data is particularly compelling. Average pain reduction exceeded 50% from baseline, functional improvement was significant and durable, and a substantial proportion of patients achieved what researchers call a minimal clinically important difference — meaning the improvement was large enough to be meaningful in daily life, not just statistically significant on a scale.
Comparison to Spinal Fusion
Perhaps the most clinically significant evidence comes from a prospective comparative study that directly compared outcomes of basivertebral nerve ablation to lumbar spinal fusion in patients with similar diagnoses. BVN ablation produced outcomes that were statistically comparable to fusion at one and two years — with significantly lower procedural risk, faster recovery, no implanted hardware, and preservation of spinal motion at the treated levels.
This finding is important because lumbar spinal fusion for discogenic pain — while commonly performed — carries substantial surgical risk, a long recovery, and mixed long-term outcomes in the literature. A minimally invasive procedure that achieves comparable relief with far less risk and downtime represents a meaningful advancement in treatment options for this patient population.
Durability
Five-year follow-up data from the original pivotal trials has shown that treatment effects are durable over time, with the majority of patients maintaining their improvements well beyond the immediate post-procedure period. This long-term durability distinguishes BVN ablation from treatments like corticosteroid injections, which typically provide temporary relief.
What to Expect: The Procedure
Basivertebral nerve ablation is typically performed in an outpatient surgical center under light sedation, though the level of anesthesia used may vary by physician and patient preference.
You will be positioned face down on a procedure table. Using fluoroscopic guidance, your doctor will introduce a small working cannula — a narrow tube — through the back of the pedicle of the target vertebral body, a technique called a transpedicular approach. The pedicle is the bony bridge connecting the back of the vertebral body to the rest of the posterior spine, and this approach provides direct access to the center of the vertebral body where the basivertebral nerve runs.
Once the cannula is in position, a specialized radiofrequency probe is advanced through it to the target location adjacent to the basivertebral nerve. Radiofrequency energy is then delivered for a defined period, creating a controlled thermal lesion that disrupts the nerve's ability to transmit pain signals. The procedure is performed at each target vertebral level, and because two levels are often treated, the cannula is repositioned as needed.
What to Expect After the Procedure
The first week
Some increase in local soreness at the procedure sites is normal and expected in the first few days. This typically resolves within one to two weeks. Over-the-counter pain relievers such as acetaminophen can be used for comfort. Most patients are able to return to light daily activities within a few days.
The recovery timeline
Unlike injections that may produce early relief from local anesthetic, BVN ablation works through a biological process following the thermal disruption of the nerve. Most patients begin to notice meaningful improvement in the weeks following the procedure, with continued improvement over the first three to six months as the nerve remodeling process completes.
Week 1–2: Procedure site soreness resolves; most patients return to light activity
Weeks 2–6: Early pain reduction begins for most patients
Months 2–3: Continued and often accelerating improvement in pain and function
Months 3–6: Most patients reach their maximum benefit by this point
Years 1–5: Evidence supports durable maintenance of improvement
Activity and rehabilitation
Your doctor will give you specific guidance on activity restrictions and return to exercise based on your individual situation. Physical therapy is typically recommended as part of the recovery process — not because the procedure requires it to work, but because restoring movement, strength, and neuromuscular control after months or years of pain-limited activity is an important part of long-term functional recovery.
How Is This Different From Other Spine Procedures?
Patients often ask how BVN ablation fits alongside the other procedures discussed in this blog — medial branch blocks, radiofrequency ablation, epidurals, and SI joint injections. The answer comes down to the specific pain generator being targeted.
Medial branch RFA targets the nerves supplying the facet joints — the small posterior joints of the spine. Epidural steroid injections target nerve root inflammation from disc herniations or spinal stenosis. SI joint injections target the sacroiliac joint. Each of these addresses a different anatomical structure.
BVN ablation targets the basivertebral nerve inside the vertebral body — a structure none of the above procedures address. This is why appropriate diagnosis is so important. A patient whose pain is coming from the endplates and basivertebral nerve will not get lasting relief from facet injections or epidurals, because those procedures are aimed at an entirely different pain generator. Identifying the correct source before choosing a treatment is the foundation of good interventional spine care.
In some patients, more than one pain generator is present simultaneously — facet arthritis and vertebrogenic pain can coexist, for example. Your doctor will evaluate your full clinical picture to determine which sources are contributing and in what proportion.
Blood Thinners and Pre-Procedure Considerations
Because BVN ablation is performed through a cannula introduced into the vertebral body, it is classified as a higher-risk procedure from a bleeding standpoint compared to most soft tissue injections. Your doctor will give you specific guidance on blood thinner management before the procedure based on your medications and overall health. Do not stop any prescription blood thinner without direct guidance from your physician.
You will also need someone to drive you home after the procedure given the sedation involved. Arrange this in advance.
Tell your doctor about all medications you take, any prior spine surgeries, any known osteoporosis or metabolic bone disease, and any implanted devices including spinal cord stimulators or hardware from prior procedures.
Insurance Coverage
Basivertebral nerve ablation is covered by Medicare and a growing number of commercial insurance plans, which reflects the strength of its clinical evidence base. Coverage policies vary by payer, and prior authorization is typically required. Your doctor's office will work with your insurance company to determine coverage and complete the authorization process before scheduling the procedure.
For patients whose insurance does not cover the procedure, self-pay options may be available. Discuss this directly with the office if coverage is a concern.
Risks and Complications
BVN ablation is a safe procedure when performed by a trained physician using image guidance, and serious complications are uncommon. Possible risks include:
Procedure site soreness — very common, resolves within one to two weeks
Incomplete or no relief — not all patients respond, and outcomes depend significantly on accurate patient selection
Infection — rare, as sterile technique is used throughout; any procedure introducing a cannula into bone carries a small infection risk
Bleeding or hematoma — uncommon with appropriate blood thinner management
Nerve injury — very rare when the transpedicular approach is performed under fluoroscopic guidance by an experienced physician
Vertebral fracture — rare, most relevant in patients with underlying osteoporosis or metabolic bone disease
Questions to Ask Your Doctor
Do my MRI findings show Modic changes, and if so, what type and at which levels?
Based on my history and imaging, do you believe the basivertebral nerve is my primary pain generator?
Have other pain sources — facet joints, sacroiliac joint, disc herniation — been adequately evaluated and ruled out?
How many levels will be treated?
Is this procedure covered by my insurance, and what does the prior authorization process look like?
What physical therapy or rehabilitation program do you recommend after the procedure?
What results are realistic based on my specific findings?
If BVN ablation does not provide adequate relief, what are the next steps?
This article is for educational purposes only and does not replace a conversation with your physician. Treatment decisions should always be made together with your care team based on your individual history, exam findings, and imaging. Study references cited in this article reflect the published literature at the time of writing. If you have questions about whether basivertebral nerve ablation is right for you, please schedule a consultation.